Metformin May Prolong Gestation in Women With Preterm Preeclampsia
No difference seen in circulating concentrations of soluble fms-like tyrosine kinase-1, placental growth factor, soluble endoglin
Endocrine Disorders
RAI Therapy for Hyperthyroidism Not Tied to Overall Cancer Risk
However, linear radiation dose-response association between radioactive iodine and solid cancer mortality seen in two studies
Warning Letters Sent to Companies Selling Supplements Claiming to Treat Diabetes
The FDA has not evaluated these products for safety or effectiveness.
Consensus Statement Defines Remission of Type 2 Diabetes
Remission defined as HbA1c <6.5 percent for at least three months after cessation of glucose-lowering pharmacotherapy
Vitamin D Does Not Impact Kidney Outcomes in Prediabetes
Secondary analysis of randomized trial shows no difference in progression of KDIGO risk scores with daily vitamin D versus placebo
Skytrofa Approved as Once-Weekly Growth Hormone Deficiency Therapy
The approval was based on data from the phase 3 heiGHt trial that assessed Skytrofa in 161 treatment-naïve, prepubertal patients with growth hormone deficiency.
Additional Dosing Options of Tirosint-SOL Now Available
Tirosint-SOL is approved for the treatment of hypothyroidism and for pituitary thyrotropin suppression.
USPSTF Says Start Diabetes Screen at Age 35 for Those With Overweight, Obesity
Overweight or obese adults should be screened for prediabetes, type 2 diabetes and offered or referred for preventive interventions
FDA Approves New Formulation of Gvoke for Severe Hypoglycemia
The FDA has approved the new Gvoke® Kit formulation for the treatment of severe hypoglycemia in patients with diabetes 2 years of age and older.
Jemperli Gets Accelerated Approval for dMMR Recurrent or Advanced Solid Tumors
The accelerated approval was based on data from the phase 1 GARNET trial.
